The Effectiveness of Evaluating Mumps Vaccine Effectiveness
Author(s) -
P. A. Brunell
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/520027
Subject(s) - subclinical infection , medicine , mumps vaccine , mumps virus , viral shedding , parotitis , isolation (microbiology) , transmission (telecommunications) , vaccination , vaccine failure , disease , virology , virus , immunology , pediatrics , surgery , biology , microbiology and biotechnology , measles , electrical engineering , measles vaccine , engineering
mumps. If the objective is to simply decrease clinical illness, the evaluation of cases of mumps parotitis is adequate. If the goal is to interrupt transmission, subclinical cases must also be considered, because individuals with these cases shed virus [2] and presumably are capable of spreading infection. The failure of isolation of patients with mumps to prevent the spread of disease has been attributed to the shedding of virus prior to or in the absence of parotid swelling [2]. If comparisons are made between vaccinated and unvaccinated groups, the effect of prior subclinical infection should not affect efficacy estimates, because the
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom